Thrombotic Thrombocytopenic Purpura after Autologous Peripheral Blood Stem Cell Transplantation / 대한진단검사의학회지
The Korean Journal of Laboratory Medicine
;
: 129-132, 2005.
Artigo
em Coreano
| WPRIM
| ID: wpr-156948
ABSTRACT
Thrombotic thombocytopenic purpura (TTP) is a serious complication following stem cell trans-plantation (SCT). Although therapeutic plasma exchange offers an encouraging treatment modality in classic TTP, this does not appear to be effective in its management of TTP following SCT. This patient with malignant lymphoma developed TTP two months after autologous peripheral blood SCT and was effectively treated with plasma exchange and steroid therapy. Plasma exchange with fresh frozen plasma and albumin was performed 14 times in 40 days. Even though TTP may emerge as a complication of autologous peripheral blood SCT, this report suggests that the risk of developing TTP after autologous peripheral blood SCT may be low and a multiple course of plasma exchange may be an effective treatment in this patient.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Plasma
/
Troca Plasmática
/
Púrpura
/
Púrpura Trombocitopênica Trombótica
/
Células-Tronco
/
Transplante de Células-Tronco de Sangue Periférico
/
Linfoma
Limite:
Humanos
Idioma:
Coreano
Revista:
The Korean Journal of Laboratory Medicine
Ano de publicação:
2005
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS